Genetic Tests On The Internet: Understanding The Dangers-And Opportunities-For Your Lab!
Trisha Brown, MS, CGC, Vice President Clinical Affairs, DNA Direct
Robert L. Michel, Editor-In-Chief, THE DARK REPORT
Genetic testing has hit the Internet! Now, any consumer with a computer and access to the Web can find a company-often with absolutely no connection to healthcare or professional medical services-offering genetic tests for just about anything. For the right price, of course.
Whether you’re a laboratory professional, pathologist, scientist, clinical chemist or lab administrator, you should be concerned about the threat of unregulated genetic tests offered by Internet companies to any consumer willing to pay for it. Because these offerings can, and will, have an impact on your bottom line.
When consumers can bypass physicians and established medical laboratories to get their own genetic tests-whether for serious illnesses or something more frivolous, like predicting eye color or a person’s musical talents-there’s no turning back. In this new, Internet-dominated world of genetic testing, pathologists and other clinically trained laboratory professionals like you will no longer be the first choice for your expertise, advice, and support.
Get answers to your own questions and learn what steps you can take to protect your lab when you hear THE DARK REPORT for, “Genetic Tests On The Internet: Understanding The Dangers-And Opportunities-For Your Lab!”
THE DARK REPORT AUDIO CONFERENCE DETAILS:
COST: $245 per live 90 minute digital recording
TO ORDER AUDIO: Click here or call 1-800-560-6363 toll-free
For one low price-just $245 -you and your entire team can take part in this fast-paced, insightful audio conference. Best of all, you’ll be able to connect personally with our speakers when we open up the phone lines for live Q&A.
Here’s just some what you’ll learn during this comprehensive 90-minute audio conference:
- Why growing numbers of consumers are seeking out genetic tests online and are willing to pay $1,000 or more (out of pocket) for them.
- How technological changes now allow companies to offer genetic testing and molecular diagnostics online directly to consumers.
- DNA Direct’s successful business model as an Internet-based, scientifically validated source of genetic tests, professional counseling services, and comprehensive information-and how this model could work for your company, too.
- The business strategies of companies like 23andMe.com, Navigene.com, and DecodeGenetics.com that attracted substantial capital investments from companies like Google.
- How to anticipate the consequences of this trend and its impact on your lab.
- How to master the strategies that can help your lab compete in this new online genetic testing world.
- Proven methods for developing consumer-friendly approaches to serving local customers who come to your clinical lab or pathology group with questions about genetic testing.
…and much more!
Trisha Brown MS, CGC, is the Vice President of Clinical Affairs for DNA Direct and is responsible for the day-to-day clinical operations and development of new clinical products and strategies. Ms. Brown is an executive with more than 16 years of experience in the business of medical genetics. Prior to joining DNA Direct, she was an Associate Vice President at LabCorp and Director of Strategic Technology Management and Implementation. In this role, she oversaw the commercialization of new technologies and developed expertise in operations, project management, strategic planning and product development. She was also responsible for LabCorp’s genetic counseling services. Ms. Brown has clinical experience and has provided genetic counseling for prenatal, craniofacial, cancer and pediatric patients. She is a board certified genetic counselor, with an M.S. degree in Human Genetics from Sarah Lawrence College.
Robert L. Michel is Editor-in-Chief of THE DARK REPORT, an intelligence service and publication providing economic and strategic assessment of the clinical laboratory industry for senior executives and pathologists. He produces the “Executive War College on Laboratory and Pathology Management,” which has an international reputation as a source of innovative and effective management strategies and business models for pathologists and laboratory executives. Mr. Michel’s expertise is strategic analysis, corporate planning and market trend assessment. He was Director of Strategic Analysis and Special Projects for the regional laboratory division of Nichols Institute prior to and through its merger with Corning Clinical Laboratories (now Quest Diagnostics Incorporated). His corporate experience includes executive positions with Proctor & Gamble Distributing Company, Financial Corp. of America and Centex Corporation. In addition, he is a winner of the Newsletter and Electronic Publisher Association’s prestigious “Best Investigative Reporting” Award and is listed in Marquis Who’s Who in Healthcare and Medicine. Mr. Michel earned a B.A. in Economics from UCLA.
ACCENT® Continuing Education Credit
The American Association of Clinical Chemistry (AACC) designates this program for a maximum of 1.5 ACCENT® credit hours towards the AACC Clinical Chemist’s Recognition Award. AACC is an approved provider of continuing education for clinical laboratory scientists in the states of California, Florida, Louisiana, Montana, Nevada, North Dakota, Rhode Island, and West Virginia.